Pharmacokinetics and metabolism of medroxyprogesterone acetate in patients with advanced breast cancer
- 1 October 1988
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 31 (4) , 437-441
- https://doi.org/10.1016/0022-4731(88)90312-3
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administration in advanced cancer patientsCancer Chemotherapy and Pharmacology, 1983
- Medroxyprogesterone acetate in human serumThe Journal of Steroid Biochemistry and Molecular Biology, 1981
- In VivoMetabolism of Progestins. V. The Effect of Protocol Design on the Estimated Metabolic Clearance Rate and Volume of Distribution of Medroxyprogesterone Acetate in Women*Journal of Clinical Endocrinology & Metabolism, 1979
- A radioimmunoassay for serum medroxyprogesterone acetateThe Journal of Steroid Biochemistry and Molecular Biology, 1978
- Serum Medroxyprogesterone Acetate (MPA) Concentrations and Ovarian Function Following Intramuscular Injection of Depo-MPAJournal of Clinical Endocrinology & Metabolism, 1977
- Radioimmunoassay for medroxyprogesterone acetate (Provera®) using the 11α-hydroxy succinyl conjugateSteroids, 1974